Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tharimmune ( (THAR) ) has provided an announcement.
On October 10, 2025, Tharimmune, Inc. filed a Certificate of Amendment with the Secretary of State of Delaware to increase its authorized shares of Common Stock from 250 million to 1 billion. This significant increase in authorized shares could potentially impact the company’s operations and market positioning by providing more flexibility for future financing and growth opportunities.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 10,003,935
Technical Sentiment Signal: Hold
Current Market Cap: $17.51M
See more data about THAR stock on TipRanks’ Stock Analysis page.